- CONTACT US
- AFS
- Business
- Bussiness
- Car
- Career
- Celebrity
- Digital Products
- Education
- Entertainment
- Fashion
- Film
- Food
- Games
- General Health
- Health
- Health Awareness
- Healthy
- Healthy Lifestyle
- History Facts
- Household Appliances
- Internet
- Investment
- Law
- Lifestyle
- Loans&Mortgages
- Luxury Life Style
- movie
- Music
- Nature
- News
- Opinion
- panorama
- Pet
- Plant
- Politics
- promis
- Recommends
- Science
- Self-care
- services
- Smart Phone
- sport
- Sports
- Style
- Technology
- tire
- Travel
- US
- World
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Eating Brie, Gouda, cheddar may lower dementia risk, new study says - 2What is the 'Survivor 50' Challenge? Hidden immunity idols will be up for grabs in every U.S. state.
- 3Kate Middleton and Prince William unveil annual family Christmas card photo with George, Charlotte and Louis
- 4Tributes pour in for MIT professor Nuno Loureiro amid unresolved shooting case
- 5Interstellar comet 3I/ATLAS to pass closest to Earth on Friday
- Takeda's AI-crafted psoriasis pill succeeds in late-stage studies
- Ukrainian Army Converts E38 BMW 7-Series Into Multiple Rocket Launch Platform
- Cocoa Prices Settle Lower on Expectations of Adequate Supplies
- Exclusive-Head of Pemex's production arm to step down in coming days, sources say
- ONE returns to Red Sea with new service
- SpaceX launches Starlink missions in dual-coast spaceflight doubleheader (videos)
- Check out the exclusive pitch deck Valerie Health used to raise $30 million from Redpoint Ventures to automate healthcare faxes
- EU waters down plans to end new petrol and diesel car sales by 2035
- Falcon 9 rocket launches Starlink satellites before making 550th SpaceX landing (video)
- Trump said affordability is a ‘hoax’ in his Pennsylvania speech. What do the latest numbers show?
